Clinical Trial Update: Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation [NA]

View source ↗

Summary

Completed clinical trial evaluating the WATCHMAN left atrial appendage closure device for stroke prevention in patients unsuitable for oral anticoagulation; thi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• WATCHMAN Left Atrial Appendage Closure Device (Left atrial appendage closure device)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Stroke | NA | Status: COMPLETED